SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
AXA S.A. (AXAHF) trades at a trailing P/E of 10.2, forward P/E of 11.7. Trailing earnings yield is 9.78%, forward earnings yield 8.53%. PEG 0.30 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (10.2); PEG ≤ 1.0 — Peter Lynch undervalued (0.30); earnings yield beats bond yields (9.78%).
- PEG Ratio 0.30 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 9.78% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
Overall SharesGrow Score: 77/100 with 5/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — AXAHF
Valuation Multiples
P/E (TTM)10.2
Forward P/E11.7
PEG Ratio0.30
Forward PEG2.06
P/B Ratio0.00
P/S Ratio0.87
EV/EBITDA0.0
Per Share Data
EPS (TTM)$4.68
Forward EPS (Est.)$4.08
Book Value / Share$0.00
Revenue / Share$55.24
FCF / Share$0.00
Yields & Fair Value
Earnings Yield9.78%
Forward Earnings Yield8.53%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$2.30 |
$121.8B |
$5.56B |
4.6% |
| 2017 |
$2.49 |
$128.42B |
$5.98B |
4.7% |
| 2018 |
$0.79 |
$100.93B |
$1.88B |
1.9% |
| 2019 |
$1.51 |
$124.94B |
$3.86B |
3.1% |
| 2020 |
$1.25 |
$102.58B |
$3.16B |
3.1% |
| 2021 |
$2.97 |
$111.69B |
$7.29B |
6.5% |
| 2022 |
$2.12 |
$93.08B |
$6.68B |
7.2% |
| 2023 |
$3.13 |
$87.15B |
$7.19B |
8.2% |
| 2024 |
$3.50 |
$89.82B |
$7.89B |
8.8% |
| 2025 |
$4.68 |
$115.48B |
$9.79B |
8.5% |
